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REMAND: THE FINAL STEP IN THE MDL PROCESS—
SOONER RATHER THAN LATER
Judge Joseph R. Goodwin*
I. INTRODUCTION
In theory, the final stage of multidistrict litigation (“MDL”) is remand.1
“The authority to remand an action to the transferor court rests with the [Judicial
Panel on Multidistrict Litigation (the “Panel”)]… and not with the transferee
court.”2 “The Panel is empowered to separate any claim, cross-claim, counterclaim, or third-party claim and remand any of such claims before the rest of the
action.”3 A transferee court’s suggestion of remand to the Panel, however, is
tantamount to an order of remand because the Panel gives great deference to a
transferee judge’s suggestion.4 Ordinarily, the transferee court lacks authority to
try actions transferred from other jurisdictions. Accordingly, cases transferred to
an MDL must be remanded to their home district at or before the conclusion of
MDL pretrial proceedings.5
After handling nine product liability MDLs, I have concluded that one of
the greatest failures in multidistrict litigation is the extraordinarily long time that
cases linger in transferee courts. I have come to believe that in any adversarial
proceeding, including multidistrict litigation, definite timeframes should be
required. Establishing a fixed timeframe for an MDL proceeding in a transferee
court will strongly encourage the parties to settle or have their cases scattered by
remand or transfer.
II. THE HISTORY, LAW, AND THE PROCESS OF MDL LITIGATION
The multidistrict venue statute, 28 U.S.C. § 1407, originated in the late
1960s as a tool to permit the management of federal court cases on a nationwide
basis. The need for multidistrict litigation became “evident during the pendency of
numerous civil antitrust cases relating to the electrical equipment industry.”6 Fifty
years later, in 2018, the MDL cases in the country totaled “over 134,000 pending
* Joseph R. Goodwin was appointed in 1995 by President Clinton as United States District Judge
for the Southern District of West Virginia and remains on active status. He graduated from the
West Virginia University College of Law in 1970 and practiced law in Charleston, West Virginia,
for twenty-five years. He served a term as Chief Judge. He handled two pharmaceutical MDL
matters and one very brief consumer product MDL before the assignments of multiple MDLs
encompassing more than 100,000 pelvic mesh product cases.
1
This section also addresses the court’s role in transfer pursuant to 28 U.S.C. § 1407.
2
John G. Heyburn II, A View from the Panel: Part of the Solution, 82 TUL. L. REV. 2225, 2234 n.48
(2008) (citing In re Roberts, 178 F.3d 181, 183 (3d Cir. 1999)).
3
See Lori J. Parker, Causes of Action Involving Claim Transferred to Multidistrict Litigation, in 23
CAUSES OF ACTION § 13 (2d ed. 2013); see also 28 U.S.C. § 1407(a) (2020); § 1407 r. 7.6(c); PAUL
D. RHEINGOLD, MASS TORT LITIGATION § 4:3 (1996).
4
Heyburn, supra note 2, at 2235.
5
See Lexecon, Inc. v. Bershad, 520 U.S. 1227 (1997).
6
David F. Herr & Nicole Narotzky, The Judicial Panel's Role in Managing Mass Litigation, in
A.L.I.-A.B.A. COURSE OF STUDY: MASS LITIGATION 249, 254 (2008).
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actions spread across 196 active MDL dockets,” and comprised fifty-two percent
of federal civil cases.7
Pursuant to 28 U.S.C. § 1407(a), “[e]ach action so transferred shall be
remanded by the [P]anel at or before the conclusion of such pretrial proceedings
to the district from which it was transferred unless it shall have been previously
terminated ….”8 The MDL court issues a suggestion of remand to the Panel, and
the Panel issues a conditional order of remand. The case is held for seven days and
then, assuming there is no objection, the conditional order of remand becomes
effective and the case is then transferred.
Conversely, the court need not formally notify the Panel with respect to
direct filed cases when sending such cases to the appropriate jurisdiction. Cases
cannot be direct filed as a matter of right. The MDL statute, as interpreted by the
Supreme Court in Lexecon, Inc. v. Bershad, 520 U.S. 1227 (1997), “does not allow
the MDL court to override personal-jurisdiction and venue requirements to achieve
complete jurisdiction over a case.”9 Defendants, however, can waive these
defenses in order to allow direct filing. Case-wide direct filing stipulations are
common in MDL litigation to avoid inefficiencies and inconsistencies that
accompany defendants individually granting permission on a case-by-case basis.10
Nevertheless, some MDL courts are unwilling to allow plaintiffs to direct file, even
when defendants waive these defenses, when it is clear that other courts would be
more convenient and appropriate forums.11 Cases directly filed with an MDL court
may be transferred by the MDL court, pursuant to 28 U.S.C. § 1404, “to any other
district or division where it might have been brought or to any district or division
to which all parties have consented.”12
Generally, remand “is required when centralized proceedings have
concluded, but one or more transferred cases remains unresolved. When discovery
has been completed, pretrial motions have been ruled upon, and reasonable
attempts to try to settle the actions have not borne fruit . . . .”13 The same is true for
cases filed directly in an MDL. Most cases originally filed in or transferred to an
MDL settle long before the transferee court suggests remands or transfers the cases
back to the home jurisdictions.
The decision to direct file in the MDL court or be subject to remand by the
Panel to the court in which the case was originally filed impacts the final stages of
multidistrict litigation. Cases transferred by the Panel pursuant to 28 U.S.C. § 1407
Alan Fuchsberg & Alex Dang, MDLs Are Redefining the US Legal Landscape, LAW360 (Oct. 30,
2019, 5:48 PM), https://www.law360.com/articles/1214276/mdls-are-redefining-the-us-legallandscape.
8
§ 1407(a).
9
Andrew D. Bradt, The Shortest Distance: Direct Filing and Choice of Law in Multidistrict
Litigation, 88 NOTRE DAME L. REV. 759, 797 (2012).
10
See id.
11
Id.
12
§ 1404(a).
13
Barbara J. Rothstein & Catherine R. Borden, Managing Multidistrict Litigation in Products
Liability Cases: A Pocket Guide for Transferee Judges, FED. JUDICIAL CTR. 48 (2011),
https://www.jpml.uscourts.gov/sites/jpml/files/FJC-2011Managing%20MDL%20PL%20Pocket%20Guide.pdf.
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must be returned to the jurisdiction from which they originated. Whereas, pursuant
to the requirements of 28 U.S.C. § 1404, the MDL judge has discretion regarding
where to send direct filed cases.
III. STATISTICS IN PELVIC MESH MDLs
The pelvic mesh MDLs assigned to me followed the routine pattern, and
very few of the MDL cases actually ended in the jurisdiction where they originated
or otherwise belonged. This is not surprising because:
[s]ince its creation in 1968, the Panel has centralized 462,501 civil
actions for pretrial proceedings. By the end of 2013, a total of 13,432
actions had been remanded for trial, 398 actions had been reassigned
within the transferee districts, 359,432 actions had been terminated in the
transferee courts, and 89,123 actions were pending in 271 multidistrict
litigation dockets throughout 56 transferee district courts.14

“Indeed, the incentive structure for controlling stakeholders (lead plaintiffs’
attorneys, defendants, and transferee judges) and the procedural requirements for
remand are stacked so heavily in favor of settlement that remanding even 2.9% of
cases is remarkable.”15
In 2010, the Panel began assigning cases to me involving product liability
actions against manufacturers of pelvic mesh products used to treat stress urinary
incontinence and pelvic organ prolapse in women. What began as a handful of
cases against one manufacturer in one MDL quickly grew to seven MDLs assigned
by the Panel, which involved seven different manufacturers of multiple pelvic
mesh products and just over 100,000 total cases.16 The Panel assigned the second,
third, fourth and fifth MDLs (AMS, Boston Scientific, Ethicon, and Coloplast,
respectively) in 2012, the sixth (Cook) in 2013, and the seventh (Neomedic) in
2014.17 Most of the cases in the MDLs assigned to me were direct filed rather than
transferred. This group of MDLs is unique in its number of cases and the number
of defendants, but the statistics in these MDLs reveal that, like any other MDL,
most MDL cases settle before they are ever remanded or transferred.
Of the 101,968 cases originally filed, to date, I have placed 1,301, or 1.276
percent of the total cases, on remand or transfer orders. In many cases, after
entering the remand or transfer order, but before actual remand or transfer, the
parties dismissed the case. Of the original 1,301 cases placed on remand or transfer
orders, I remanded or transferred only 973 cases, or .954 percent of the total cases.
Judicial Panel on Multidistrict Litigation – Judicial Business 2013, U.S. COURTS (2013),
http://www.uscourts.gov/Statistics/JudicialBusiness/2013/judicial-panel-multidistrictlitigation.aspx.
15
Elizabeth Chamblee Burch, Remanding Multidistrict Litigation, 75 LA. L. REV. 399, 416 (2014).
16
At its height, I had 101,357 cases which comprised a large percentage of civil cases filed in federal
courts throughout the country.
17
The MDL case names and numbers are: C.R. Bard, Inc. 2:10-md-2187; American Medical
Systems, Inc. 2:12-md-2325; Boston Scientific Corp. 2:12-md-2326; Ethicon, Inc. 2:12-md-2327;
Coloplast Corp. 2:12-md-2387, Cook Medical, Inc. 2:13-md-2440 and Neomedic 2:14-md-2511.
14
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The two charts below indicate the number of cases initially placed on a
remand or transfer order, and then ultimately remanded or transferred in each of
the seven MDLs.

MDL

MDL
No.

C. R. Bard, Inc.
American Medical
Systems, Inc.
Boston Scientific
Corp.
Ethicon, Inc.
Coloplast Corp.
Cook Medical, Inc.
Neomedic
Totals

2187

MDL

MDL
No.

C. R. Bard, Inc.
American Medical
Systems, Inc.
Boston Scientific
Corp.
Ethicon, Inc.

2187

Coloplast Corp.
Cook Medical, Inc.
Neomedic
Totals

REMANDS
Total
Total No.
No. of
of Cases
Cases
Actually
with
Remanded
Remand
Orders
6
6

Total No.
of Cases
Not
Remanded

Total No. of
Cases with
Remands
Pending

0

0

2325

5

5

0

0

2326
2327
2387
2440
2511

10
184
1
0
0
206

10
140
1
0
0
162

0
41
0
0
0
41

0
3
0
0
0
3

DIRECT FILED CASES
Total
Total No. of Total No. of
No. of
Cases
Cases
Cases
Actually
Closed Not
with
Transferred Transferred
Transfer
Orders
83
49
34

Total No.
of Cases
with
Transfers
Pending
0

2325

44

44

0

0

2326

144

93

51

0

2327

790

601

152

37

2387

34

24

10

0

2440

0

0

0

0

2511

0

0

0

0

1095

811

247

37
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The above statistics provide important context. Very few cases that begin
in an MDL actually end up back in their home jurisdiction. In the pelvic mesh
MDLs, less than one percent actually made it all the way home to the appropriate
jurisdiction.
IV. OBSERVATIONS AND RECOMMENDATIONS
My experience with a very large number of cases assigned to me by the
Panel involving pelvic mesh products has followed the rather typical process of
emphasizing settlement in the transferee court. By the usual metric, these cases
have been MDL successes because nearly all have settled before remand or
transfer. We employed the usual practices of general and specific causation work
up, motion practice, and preparing and trying bellwether cases. However, my now
long experience with these MDLs leads me to conclude that the singular emphasis
on settlement almost always results in enormous delay. That delay may deny the
parties timely justice and is rightly considered by many as a major failure of the
MDL paradigm. Over time I have come to believe that a different approach to
product liability MDLs is justified.
It is certainly desirable to achieve resolution in the transferee court by
settlement. I now believe that a more rigidly structured approach to scheduling by
the transferee judge will result in nearly as many settlements, but with resolution
of the cases in a timelier fashion. A firm deadline for concluding proceedings in
the transferee court and remanding or transferring unresolved cases should be
established very early on in the litigation. The schedule must be generous and
recognize the standard practices, as well as the invariable vagaries of multidistrict
litigation. The court should provide ample time for organization by the leadership
appointed by the court. I believe this to be the most critical step in multidistrict
litigation.
The organizational phase is followed by planned and agreed-upon
expediencies, such as the filing of master complaints and answers, and then by
uniform disclosures of claimed facts by each plaintiff, discovery related to
defendants’ product, and development of the theories of general causation. Most
of the claim-specific discovery can be delayed so long as the fact sheets the court
requires plaintiffs to submit are comprehensive and completed in a timely manner.
The whole purpose of requiring fact sheets and general causation discovery early
in the process before the transferee court is to facilitate knowledgeable settlement
discussions. Other specific and more detailed discovery is ultimately for trial
preparation. Though it is beyond the scope of this article to discuss further details
of an MDL schedule, it is sufficient to say I believe that an inviolate remand or
transfer date set after careful planning, which allows generous time for each step
of discovery and permits generally applicable motion practice, will result in fairer
and faster resolution of the cases.
Judges and members of the bar experienced in multidistrict litigation have
come to expect the selection and trial of bellwether cases, but this does not
necessarily interfere with my recommendation. I think it critically important that
the transferee judge not permit preparation of bellwether cases to delay or interrupt
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the progress of common discovery and adherence to the schedule. It is perfectly
possible to treat those cases somewhat separately from the discovery process, and
thus not interfere in developing the mass of cases in the MDL.
A firm deadline for the completion of discovery, general motion practice,
and remand or transfer forces settlement negotiations to proceed apace. Much of
the delay in settlement occurs when the parties are permitted to procrastinate.
Knowing that your cases will be dispersed across the country if you do not settle
before the remand or transfer deadline will be strong incentive to prepare earlier,
evaluate sooner, and negotiate seriously. All processes for the resolution of
disputes must be delimited. To the extent that there is an amorphous structure, the
MDL process is flawed.
I further recommend an approach that bifurcates the efforts in the
transferee court along two distinct paths. One path focuses upon the discovery and
motion practice. This path deals with the bellwether cases and preparation for
remand or transfer and trial. The other path is devoted to settlement discussions.
Ultimately, in this two-path system, there are two separate leadership teams. One
set of plaintiffs’ leadership and defendants’ leadership deals with case
development and the other set deals with settlement. The transferee court needs to
be consistently and actively involved in facilitating settlements and superintending
discovery and motion practice. Multidistrict litigation is a practical necessity and
it can and should be an expeditious and just means for the resolution of these
product liability cases.
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